Menu

Blog

Archive for the ‘biotech/medical’ category: Page 378

Jan 28, 2024

Smartphone Spectroscopy Takes the Lab to the People

Posted by in categories: biotech/medical, mobile phones

By 2020, the number of smartphone users in the world is expected to reach almost 2.9 billion — nearly doubling in six years from about 1.6 billion in 2014. Technology companies and researchers have been directly and indirectly imbuing smartphones with additional capabilities, including spectroscopy for biological and medical applications, among other uses (Figure 1).

Figure 1. The Changhong H2 is the first consumer device with an integrated imaging spectrometer. Courtesy of Consumer Physics.

Jan 27, 2024

Scientists explore DNA hacking for functional 3D nanostructures

Posted by in categories: biotech/medical, cybercrime/malcode, nanotechnology

Scientists use DNA hacking to create a variety of 3D metallic and semiconductor nanostructures for advanced technologies.

Jan 27, 2024

Outcomes in Takotsubo Syndrome and Associations with Medication Use

Posted by in category: biotech/medical

Patients with takotsubo syndrome in a new study had elevated cardiovascular and noncardiovascular death rates. Inhibitors of the renin-angiotensin system were the only cardiovascular medications associated with reduced risk.


In takotsubo syndrome (TS) — also called stress cardiomyopathy or broken heart syndrome — long-term mortality is elevated, similar to that after acute myocardial infarction (AMI), but for unclear reasons. Additionally, evidence-based therapies are lacking for TS. To explore causes of death and the effects of heterogeneous therapies for TS, investigators in Scotland compared outcomes between 620 patients with TS, 620 matched patients presenting with AMI, and 2,480 matched individuals from the general population. Median follow-up was 5.5 years.

Among patients with TS, all-cause mortality was higher compared with the general population (hazard ratio, 1.8), both for cardiovascular causes (HR, 2.5) and noncardiovascular causes (HR, 1.5), but was lower compared with patients with AMI (HR, 0.8). Patients with TS were prescribed cardiovascular and noncardiovascular medications at similar rates to those with AMI. Use of diuretics, anti-inflammatory agents, and psychotropic agents were associated with higher mortality in patients with TS, as was chronic anti-inflammatory medication use. The only medications associated with lower mortality in patients with TS were inhibitors of the renin-angiotensin system.

Continue reading “Outcomes in Takotsubo Syndrome and Associations with Medication Use” »

Jan 27, 2024

Healthy eating and activity reverse aging marker in kids with obesity, study finds

Posted by in categories: biotech/medical, food, genetics, life extension

A genetic marker linked to premature aging was reversed in children with obesity during a six-month diet and exercise program, according to a recent study led by the Stanford School of Medicine.

Children’s telomeres—protective molecular “caps” on the chromosomes—were longer during the weight management program, then were shorter again in the year after the program ended, the study found. The research was published last month in Pediatric Obesity.

Like the solid segment at the end of a shoelace, telomeres protect the ends of chromosomes from fraying. In all people, telomeres gradually shorten with aging. Various conditions, including obesity, cause premature shortening of the telomeres.

Jan 27, 2024

Optimizing Gene Editing with PARP1 CRISPR Plasmids

Posted by in categories: bioengineering, biotech/medical, genetics, health

Gene editing is revolutionizing the understanding of health and disease, providing researchers with vast opportunities to advance the development of novel treatment approaches. Traditionally, researchers used various methods to introduce double strand breaks (DSBs) into the genome, including transactivator-like effectors, meganucleases, and zinc finger nucleases. While useful, these techniques are limited in that they are time and labor intensive, less efficient, and can have unintended effects. In contrast, the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein-9 (Cas9) system (CRISPR/Cas9) is among the most sensitive and efficient methods for creating DNA DSBs, making it the leading gene editing technology.

CRISPR/Cas9 is a naturally occurring immune protective process that bacteria use to destroy foreign genetic material.1 Researchers repurposed the CRISPR/Cas9 system for genetic engineering applications in mammalian cells, exploiting the molecular processes that introduce DSBs in specific sections of DNA, which are then repaired to turn certain genes on or off, or to correct genomic errors with extraordinary precision.2,3 This technology’s applications are far reaching, from cell culture and animal models to translational research that focuses on correcting genetic mutations in diseases such as cancer, hemophilia, and sickle cell disease.4

Researchers exploit plasmids, the small, closed circular DNA strands native to bacteria, as delivery vehicles in CRISPR/Cas9 gene editing protocols. Plasmids shuttle the CRISPR/Cas9 gene editing components to target cells and can be manipulated to control gene editing activity, including targeting multiple genes at a time. Plasmids can also deliver gene repair instructions and machinery. For example, poly (ADP-ribose) polymerase 1 (PARP1) is an enzyme that drives DNA repair and transcription.5 It is a critical aspect of CRISPR/Cas9 gene editing technology in part because it helps repair the DSBs created by the CRISPR/Cas9 system. PARP1 CRISPR plasmids can edit, knockout, or upregulate PARP1 gene expression depending on the specific instructions encoded in the plasmid.

Jan 27, 2024

Farmbots, flavour pills and zero-gravity beer: inside the mission to grow food in space

Posted by in categories: biotech/medical, space travel

Astronauts content themselves with freeze-dried gruel, but plans for crewed missions to Mars mean scientists need to create more delicious, nutritious menus by .

Jan 27, 2024

Age Reversal Pill Coming SOON? David Sinclair’s NEW RESEARCH

Posted by in categories: biotech/medical, life extension

Dr. David Sinclair’s groundbreaking research indicates a pill capable of reversing aging at a cellular level is possible and that even a high school student…

Jan 27, 2024

How Will An AGING CURE Impact The Environment?

Posted by in categories: biotech/medical, ethics, food, life extension

Mainly this is about vertical farming.


In this eye-opening video, we explore the complex Environmental Impacts of an Aging Cure, delving into how extending Human Lifespan and pursuing Longevity could reshape our planet. We investigate the potential for increased Population Growth, the challenges of Sustainability, and the implications for Resource Consumption. Our analysis covers the Ecological Footprint of a world where aging is a thing of the past, addressing both the ethical dilemmas and the potential for Biomedical Advances in Age-Related Research. As concerns about Overpopulation and the need for Renewable Resources come to the forefront, we examine Eco-friendly Technologies and their role in supporting an age-extended society. Join us in this critical discussion about the intersection of Environmental Ethics and the quest for Age Extension.

Continue reading “How Will An AGING CURE Impact The Environment?” »

Jan 27, 2024

How wastewater could offer an early warning system for measles

Posted by in category: biotech/medical

Sewage surveillance has helped us track polio, covid, mpox, and more. Why not measles?

Jan 27, 2024

New rapid prototyping method for microscale spiral devices

Posted by in categories: biotech/medical, engineering

A team of researchers from Tohoku University and Okinawa Institute of Science and Technology (OIST) has achieved significant advancement in the field of microfluidics, allowing for precise and efficient manipulation of fluids in three-dimensional microscale environments. This work opens up new possibilities for bioanalytical applications, such as cell separations in the realm of medical diagnostics.

Details of their breakthrough were published in the journal Microsystems & Nanoengineering on January 22, 2024.

Microfluidic devices are designed to handle minuscule fluid volumes, allowing researchers to perform analyses and processes with remarkable precision and efficiency.

Page 378 of 2,820First375376377378379380381382Last